Institutional members access full text with Ovid®

Share this article on:

Double blind placebo-controlled study of efficacy, safety and tolerance of raloxifene as an adjuvant treatment for negative symptoms of schizophrenia in postmenopausal women

Usall, Judith; Huerta, Elena; Araya, Susana; Serrano, Antoni; Roca, Mercedes; Cobo, Jesus

International Clinical Psychopharmacology: September 2011 - Volume 26 - Issue - p e72–e73
doi: 10.1097/01.yic.0000405755.65811.a8
The 15th Biennial Winter Workshop in Psychoses, 15-18 November 2009, Barcelona, Spain: Oral Platform Presentations